Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Clinical Pharmacology Insights Into Patient Care Chat Show For APICON 2025 Moundrops
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-27
Summary: Clinical Pharmacology Insights into Patient Care
Panel Discussion Overview: Moderated by Dr. Shambo Samrat Samajdar with insights from Prof. Jyotirmoy Pal, Prof. Santanu K Tripathi, Prof. Nandini Chatterjee, and Prof. Sandhiya Selvarajan, this session explored practical applications of clinical pharmacology principles in patient care.
Key Topics:
1. Polypharmacy:
High prevalence globally and in India among the elderly, often associated with increased risk of adverse outcomes.
Challenges include inappropriate medication use, undertreatment, and anticholinergic burden.
Strategies like clinical pharmacological reconciliation and review ensure safe prescribing.
2. Prescribing Cascade:
Avoid initiating medications to treat side effects of others unnecessarily.
Deprescribing emphasized as a systematic and patient-centered approach.
3. Dose Modifications:
Critical for patients with chronic kidney disease (CKD) or chronic liver disease (CLD).
Factors like hepatic extraction ratio, intrinsic clearance, and altered pharmacokinetics guide adjustments.
4. Drug-Induced Disorders:
Examples included interactions between linezolid and digoxin, highlighting the importance of therapeutic drug monitoring (TDM).
Managing adverse effects and ensuring optimal drug levels were stressed.
5. Case Studies:
Detailed cases illustrated challenges of polypharmacy, prescribing cascades, and dose adjustments in vulnerable patients.
Take-Home Messages:
Rationalize polypharmacy.
Prevent prescribing cascades.
Tailor dose modifications for CKD/CLD patients.
View deprescribing as a positive, collaborative intervention.
Focus on a patient-centric approach for safe and effective clinical pharmacological care.
Clinical Pharmacology Insights Into Patient Care Chat Show For APICON 2025 For Country: United States. City: Aurora, Indianapolis, Johnson City, Santa Clarita, Virginia Beach
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication